FDA Plans to Speed Path to Approval for Some Gene Therapies – Scientific American
Scientific American |
FDA Plans to Speed Path to Approval for Some Gene Therapies
Scientific American Specifically, gene therapies for hemophilia, a rare disease in which blood doesn’t clot properly because it lacks certain proteins, could be evaluated based on whether therapy increases those proteins in the blood, regardless of whether the therapy … What We’re Reading: “Right-to-Try” Law Set; FDA to Speed Gene Therapies; Drug Pricing Analysis Finds IncreasesAJMC.com Managed Markets Network Trending News Today: Congress Passes Right to Try Legislation for Terminally Ill PatientsSpecialty Pharmacy Times |
|
Danish Biotech Raises Series A Round to Advance Biocatalyst Technology
Labiotech.eu (blog) Other key players in the synthetic biology field include Antheia and e-NIOS. Antheia uses synthetic biology to develop plant-based medicines. e-NIOS’s cloud platform technology can analyze genetic data from a variety of sources and apply the … |
FiercePharma |
Novartis’ brand-new gene therapy player AveXis will build $55M plant, hire 200
FiercePharma “Our primary focus is to bring gene therapies to patients suffering from devastating rare neurological diseases—such as SMA, genetic amyotrophic lateral sclerosis and Rett syndrome—and continued investment in establishing our manufacturing … Gene therapy company to create 200 jobs in North Carolina :: WRAL …WRAL.com Gene therapy company to create 200 jobs in North CarolinaSacramento Bee |
BioPharma-Reporter.com |
Stem cell clinic to ‘vigorously defend’ US FDA lawsuit
BioPharma-Reporter.com The lawsuit seeks to stop USRM and related parties from performing a surgical procedure using stem cells from autologous adipose tissue. Dr. Kristin Comella, chief science officer of US Stem Cell, told us in a statement: “My entire career has been … Where bioengineering and stem cell science meet, and thriveScope (blog) Mapping the Genes Responsible for PluripotencyNews-Medical.net [Doctors with Patents] SNUH professor pursues stem cell research for real-life therapiesKim Hyo-soo pushes forward …Korea Biomedical Review Technical Progress –Expert Consulting –Exclusive Reportage all 45 news articles » |
WRAL.com |
Gene therapy company to create 200 jobs in North Carolina
WRAL.com DURHAM, N.C. — A gene therapy company says it will create 200 jobs in North Carolina. AveXis on Tuesday agreed to set up operations in Durham County, after getting a state incentive package worth up to $3 million. AveXis makes treatments for spinal … Novartis’ brand-new gene therapy player AveXis will build $55M plant, hire 200FiercePharma |
WRAL.com |
Gene therapy company to create 200 jobs in North Carolina
WRAL.com DURHAM, N.C. — A gene therapy company says it will create 200 jobs in North Carolina. AveXis on Tuesday agreed to set up operations in Durham County, after getting a state incentive package worth up to $3 million. AveXis makes treatments for spinal … Novartis’ brand-new gene therapy player AveXis will build $55M plant, hire 200FiercePharma |